Melioidosis in Papua New Guinea and Oceania by Warner, Jeffrey M. & Currie, Bart J.
Tropical Medicine and 
Infectious Disease
Article
Melioidosis in Papua New Guinea and Oceania
Jeffrey M. Warner 1,2,* and Bart J. Currie 3,4 ID
1 Australian Institute of Tropical Health and Medicine, James Cook University, Townsville 4811, Australia
2 College of Public Health, Medical and Veterinary Sciences, James Cook University,
Townsville 4811, Australia
3 Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University,
Darwin, NT 0815, Australia; Bart.currie@menzies.edu.au
4 Department of Infectious Diseases, Royal Darwin Hospital, Darwin, NT 0815, Australia
* Correspondence: jeffrey.warner@jcu.edu.au; Tel.: +61-429474977
Received: 31 January 2018; Accepted: 6 March 2018; Published: 15 March 2018
Abstract: Melioidosis has only been sporadically reported throughout Melanesia and the Pacific
region since the first report from Guam in 1946; therefore, its contribution to the disease burden in this
region is largely unknown. However, the outcome of a small number of active surveillance programs,
serological surveys, and presumptive imported cases identified elsewhere provide an insight into its
epidemiology and potential significance throughout the region. Both clinical cases and environmental
reservoirs have been described from the rural district of Balimo in the Western Province of Papua
New Guinea and from the Northern Province of New Caledonia. In both these locations the incidence
of disease is similar to that described in tropical Australia and Burkholderia pseudomallei isolates are
also phylogenetically linked to Australian isolates. Serological evidence and presumptive imported
cases identified elsewhere suggest that melioidosis exists in other countries throughout the Pacific.
However, the lack of laboratory facilities and clinical awareness, and the burden of other infections of
public health importance such as tuberculosis, contribute to the under-recognition of melioidosis in
this region.
Keywords: Papua New Guinea; Oceania; melioidosis
1. History
The Western Pacific is home to the island communities of Oceania, including 15 countries within
Melanesia, Micronesia, Polynesia, and Australasia (Figure 1). Each of these countries has diverse
geography, demography, and socio-economic status. Melioidosis within Australasia will not be
discussed in this review.
The first reported cases of melioidosis in Oceania outside Australasia were from two military
personal stationed on Guam during World War II [1]. In Papua New Guinea (PNG), melioidosis seems
sporadic. The first reports were from animals kept in a zoo in the urban capital of Port Moresby
in 1963 [2–4]. The first human case from PNG was recorded in 1965 from a patient referred to Port
Moresby General Hospital from Gemo Island, the then-leprosarium [5]. A case of melioidosis reported
from Sydney was reported in a man with a history of World War II service in PNG [6]. Similarly,
Kingston, a year later, reported from the same repatriation hospital a case of presumptive reactivation
illness from an individual 24 years after World War II military service in Milne Bay, PNG [7]. In New
Caledonia, Burkholderia pseudomallei was first isolated from soil as part of an animal health program in
1984 [8] and the first human case was reported in 1999 [9].
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Figure 1. Map of Oceania based on the United Nations geoscheme M49 coding classification, devised 
by the United Nations Statistics Division. 
2. Review of Confirmed Human Melioidosis Cases  
2.1. Melioidosis Is Rare in PNG’s Urban Capital  
Since PNG independence in 1975, seven cases of culture-confirmed melioidosis have been 
reported from the PNG capital Port Moresby as a result of active case detection [10–13]. De Buse and 
colleagues reported a five-year-old boy presenting with pyrexia of unknown origin (PUO), who failed 
to respond to malaria treatment. Two from three blood cultures taken revealed Staphylococcus aureus. 
During exhaustive clinical work-up, B. pseudomallei along with S. aureus was recovered from a  
pus-filled nodule excised from the abdominal wall. Subcutaneous abscesses appeared which, upon 
culture, grew B. pseudomallei. Lee and Naraqi undertook a retrospective study in a review of Gram-
negative pneumonia presenting in adults at Port Moresby General Hospital between February 1977 
and May 1979. Of the 3500 adult in-patients during this time, 550 had been admitted with acute 
pneumonia. Of the 80 patients with Gram-negative bacteraemia, four were found to have primary 
pneumonia caused by B. pseudomallei. One of the cases was melioidosis pneumonia with left side 
consolidation and cavitation resembling pulmonary tuberculosis. The patient was a 36-year-old 
female who presented acutely ill with fever, cough, and pleuritic chest pain. She had a past history 
of tuberculosis but no other traditional co-morbidity factors were described. 
Melioidosis was included in a prospective study of adult atypical pneumonia at Port Moresby 
General Hospital over a ten-month period, reported in 1991 [14]. Of the 175 adults admitted to the 
study, none revealed evidence of melioidosis using culture or indirect haemagglutination (IHA) 
serology. Currie described a report of melioidosis in PNG presenting in a 28-year-old highland man 
residing in Port Moresby with fulminating pneumonia [12]. The patient had a history of excessive 
alcohol consumption, smoking, and glucose intolerance; he died a day after admission.  
Between 2000 and 2002, laboratory surveillance for B. pseudomalleiat the Port Moresby General 
Hospital Pathology Department and at the Central Public Health Laboratory, Port Moresby, was 
undertaken. From 2285 blood cultures tested from patients at Port Moresby General Hospital, two 
(0.09%; 95% CI 0.01–0.32%) were positive for B. pseudomallei. In an attempt to determine the 
prevalence of melioidosis in the tuberculosis (TB) patient cohort in Port Moresby, 1309 sputum 
samples from 529 patients were selectively cultured for B. pseudomallei; only 1/1309 was positive for 
B. pseudomallei [13]. These studies confirm that melioidosis does exist in the urban capital but it is rare, 
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2. Review of Confirmed Human Melioidosis Cases
2.1. elioidosis Is Rare in PNG’s Urban Capital
Since P G independence in 1975, seven cases of culture-confir ed elioidosis have been
reported fro the PNG capital Port oresby as a result of active case detection [10–13]. De Buse and
colleagues reported a five-year-old boy presenting with pyrexia of unknown origin (PUO), who failed
to respond to alaria treat ent. Two fro three blood cultures taken revealed Staphylococcus aureus.
During exhaustive clinical work-up, B. pseudomallei along with S. aureus was recovered from a pus-filled
nodule excised from the abdominal wall. Subcutaneous abscesses appeared which, upon culture,
grew B. pseudomallei. Lee and Naraqi undertook a retrospective study in a review of Gram-negative
pneumonia presenting in adults at Port Moresby General Hospital between February 1977 and May
1979. Of the 3500 adult in-patients during this time, 550 had been admitted with acute pneumonia.
Of the 80 patients with Gram-negative bacteraemia, four were found to have primary pneumonia
caused by B. pseudomallei. One of the cases was melioidosis pneumonia with left side consolidation and
cavitation resembling pulmonary tuberculosis. The patient was a 36-year-old female who presented
acutely ill with fever, cough, and pleuritic chest pain. She had a past history of tuberculosis but no
other traditional co-morbidity factors were described.
elioidosis was included in a prospective study of adult atypical pneumonia at Port oresby
General Hospital over a ten-month period, reported in 1991 [14]. Of the 175 adults admitted to
the study, none revealed evidence of melioidosis using culture or indirect haemagglutination (IHA)
serology. Currie described a report of melioidosis in PNG presenting in a 28-year-old highland man
residing in Port oresby with fulminating pneumonia [12]. The patient had a history of excessive
alcohol consumption, smoking, and glucose intolerance; he died a day after admission.
Between 2000 and 2002, laboratory surveillance for B. pseudomallei at the Port oresby General
Hospital Pathology Department and at the Central Public Health Laboratory, Port oresby, was
undertaken. From 2285 blood cultures tested from patients at Port oresby General Hospital, two
(0.09%; 95% CI 0.01–0.32%) were positive for B. pseudomallei. In an attempt to determine the prevalence
of melioidosis in the tuberculosis (TB) patient cohort in Port Moresby, 1309 sputum samples from
529 patients were selectively cultured for B. pseudomallei; only 1/1309 was positive for B. pseudomallei [13].
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These studies confirm that melioidosis does exist in the urban capital but it is rare, despite the large and
increasing population and increasing numbers with risk factors such as diabetes and hazardous alcohol
use [15].
2.2. Melioidosis Hotspot: The Balimo Region of the Western Province, PNG
In contrast to the rare reports of melioidosis in Port Moresby, a focus of endemicity has been
reported and studied in the remote Balimo region of the Western Province. Following an unpublished
clinical report of melioidosis in this community in 1983 [16], two periods of active case detection
were conducted as part of a broader development of microbiology facilities in the 1990s. Over an
18-month period this resulted in the diagnosis of eight culture-confirmed cases [17]. A feature of
the disease in this region is childhood predilection with chronic presentation, which can mimic TB.
Sero-epidemiology revealed a seroprevalence in some village communities as high as those in regions
in northern Australia. In the environment, particularly sites that children frequent, B. pseudomallei
was isolated (in 2.6% of 274 soil samples overall) [18]. Of 13 clinical and 26 environmental isolates
analysed, only three multi-locus sequence type (MLST)-derived genotypes have been described—the
most common being ST267, with the others (ST667 and ST668) differing from ST267 by only one SNP
in the ace gene [19]. Further phylogenetic analysis shows the origins of these isolates to be in the
Australian clade, yet some characteristics of the Asian isolates are also evident. It has therefore been
proposed that the ancient land mass that joined Australia and New Guinea 20,000 years ago during
the last ice age provided a land bridge, which may have facilitated movement of ancestral stains of B.
pseudomallei from Australia to Asia via PNG [19].
Since the late 1990s, further cases of suspected melioidosis from Balimo District Hospital have
been noted and some have been confirmed with culture of B. pseudomallei. However, the majority go
unreported due to a downgrading of laboratory and clinical facilities over recent decades in Balimo as
in many other rural locations in PNG. This includes no resident medical staff being present in Balimo
and only sporadically-available bacteriological culture facilities. In this community the emergence of
multidrug-resistant tuberculosis has also complicated the clinical diagnosis of melioidosis. Only when
the diagnostic capacity for infectious diseases is improved will the true burden of melioidosis be
realised and managed in this community.
2.3. Elsewhere in Oceania
Since the first description in Guam, melioidosis elsewhere in Oceania has been equally sporadic
and reports are opportunistic. Several cases in Australia have been attributed to infection acquired in
Fiji [20,21]. There is seroprevalence evidence from East Timor [22], but to date, no confirmed culture of
B. pseudomallei. Only in New Caledonia has melioidosis been more thoroughly studied and reported.
Similar to in PNG, the first melioidosis studies in New Caledonia were conducted and reported
by animal health workers [8]. The first human case was reported in 1999 [9]; since then, 19 melioidosis
cases have been reported and studied [23–25]. As seems the case in PNG, melioidosis in New Caledonia
is mostly restricted to one regional province, although whether there are biogeographic, demographic,
or simply healthcare access factors at play can be only determined through a thorough and structured
epidemiological and environmental study across the dispersed islands of that nation. As in Australia
and other endemic regions, the most common presentation is community-acquired pneumonia, which
may mimic TB, yet 32% presented with chronic disease including skin lesions.
As is the case in the Balimo region of PNG, there is evidence in New Caledonia of a persistent,
dominant clonal strain as defined by MLST, with ST292 being the most common in the highly-endemic
east coast region. All isolates analysed with MLST were shown to cluster—along with the other isolates
from Melanesia—within the Australian clade rather than the Asian clade [25].
In recent years there has been a cluster of fatal melioidosis cases on the island of Yap, located in
the Federated States of Micronesia (Figure 1) [26,27]. This is currently being investigated by the US
Centers for Disease Control.
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3. Current Recommendations and Availability of Measures against Melioidosis
The studies of melioidosis from isolated communities within this region highlight the difficulties in
diagnosing and treating melioidosis without appropriate laboratory and clinical facilities. It is likely—as
it almost certainly remains the case today in Balimo—that the disease carries very high mortality in such
circumstances. In many of these communities, the gold-standard parenteral antibiotics meropenem and
ceftazidime are not available. In these communities, cotrimoxazole or even chloramphenicol may be
the only available antibiotics for therapy of suspected or confirmed melioidosis.
4. Awareness of Melioidosis, and Current and Future Challenges
Melioidosis is not a notifiable disease in any country in Oceania outside Australasia; as a result,
the general awareness of the disease in this region is poor. With such limited data and such poor ability
to obtain quality data, it is therefore unwise to generalise regarding the significance of melioidosis
in Oceania. However, the evidence so far gathered and reported suggests that melioidosis is rare in
urban centres, where microbiology facilities are able to detect the organism, but is likely to remain
undiagnosed in some rural communities that lack the healthcare systems needed to identify it. With the
development of an enhanced rural medical workforce plus laboratory facilities, perhaps including
the introduction of non-culture-based detection methods that do not rely on extensive laboratory
expertise, this may change. However, the burden of other diseases of public health importance such as
multidrug-resistant TB, may yet overwhelm these developing health systems.
The spatial clustering of clinical melioidosis linked to parameters of the environmental reservoir,
the diversity of the geography, and the limited ability to diagnose infection in this region, support the
need for the establishment of a systematic remote sensing study to predict, identify, and locate regions
that may harbour unrevealed melioidosis. Until these studies are conducted, melioidosis will remain
an under-recognised, enigmatic condition, with high mortality rates.
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